Table 1—

Baseline characteristics of the 133 type 2 diabetic patients in whom endothelial function was measured in the DAL1 study

PlaceboA10A80
n444643
Male sex (%)506758
Age (years)59 ± 861 ± 761 ± 8
Duration of diabetes (years)10.1 ± 6.311.6 ± 6.612.8 ± 8.7
Insulin use (%)595658
BMI (kg/m2)32.5 ± 6.430.0 ± 3.830.6 ± 3.8
Waist-to-hip ratio0.99 ± 0.081.00 ± 0.061.01 ± 0.09
Hypertension (%)595470
Blood pressure (mmHg)144 ± 21/86 ± 9146 ± 18/87 ± 11147 ± 17/87 ± 9
Current smoking (%)232023
Fasting glucose (mmol/l)10.5 ± 4.110.5 ± 3.111.1 ± 2.8
HbA1c (%)8.4 ± 1.28.1 ± 1.28.6 ± 1.2
Total cholesterol (mmol/l)6.0 ± 0.85.8 ± 0.96.1 ± 0.9
LDL cholesterol (mmol/l)3.7 ± 0.93.7 ± 0.93.7 ± 1.0
Triglycerides (mmol/l)2.75 ± 1.062.47 ± 0.822.81 ± 1.14
HDL cholesterol (mmol/l)1.04 ± 0.21.06 ± 0.31.04 ± 0.2
  • Continuous data are expressed as means ± SD unless otherwise indicated.